Skip to main content


Erratum to: ‘Quality of life and costs of spasticity treatment in German stroke patients’

Article metrics

The original article was published in Health Economics Review 2016 6:27

Unfortunately, the original version of this article [1] contained errors. There were formatting errors in the main text and in Tables 1, 2, 3, 4, 5 and 6. These tables have been included correctly below. There will also be an update to correct the errors in the main text.

Table 1 Cost data sources
Table 2 Patient demography and other baseline characteristics
Table 3 Overview of antispastic therapies and measures during the study
Table 4 Responder analyses at study end after 1-year of treatment
Table 5 Overview of total costs by cost centers (in €)
Table 6 Overview of Cost-utility ratios and ICER


  1. 1.

    Rychlik R, Kreimendahl F, Schnur N, Lambert-Baumann J, Dressler D. Quality of life and costs of spasticity treatment in German stroke patients. Health Economics Review. 2015;6(1):1–9.

Download references

Author information

Correspondence to Fabian Kreimendahl.

Additional information

The online version of the original article can be found under doi:10.1186/s13561-016-0107-5.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark